诊疗一体化：透过黑格尔视角看放射性药物与核医学 - Suppr

Suppr

超能文献

Theragnostic: radiopharmaceuticals and nuclear medicine as viewed through Hegel's eyes.

作者信息

Boschi Stefano, Castellucci Paolo, Nanni Cristina

机构信息

Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.

Nuclear Medicine Department, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):942-946. doi: 10.1007/s00259-023-06570-0.

DOI:10.1007/s00259-023-06570-0

PMID:38114617

Abstract

摘要

相似文献

Theragnostic: radiopharmaceuticals and nuclear medicine as viewed through Hegel's eyes.

Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):942-946. doi: 10.1007/s00259-023-06570-0.

Side effects of theragnostic agents currently employed in clinical practice.

Q J Nucl Med Mol Imaging. 2021 Dec;65(4):315-326. doi: 10.23736/S1824-4785.21.03411-7. Epub 2021 Dec 9.

Creuzerstreit .

J Hist Ideas. 2019;80(2):271-288. doi: 10.1353/jhi.2019.0015.

The 'Is' and the 'Ought' of the Animal Organism: Hegel's Account of Biological Normativity.

Hist Philos Life Sci. 2022 Apr 29;44(2):17. doi: 10.1007/s40656-022-00498-8.

Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging.

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3320-3321. doi: 10.1007/s00259-022-05768-y.

Progress in nuclear medicine imaging of cancers.

Prim Care. 1998 Jun;25(2):341-60. doi: 10.1016/s0095-4543(05)70068-3.

Radiopharmaceuticals and their use in the current practice of nuclear medicine.

Lippincotts Prim Care Pract. 1999 Nov-Dec;3(6):531-45.

Current readings in nuclear medicine.

Clin Nucl Med. 1997 Feb;22(2):136-9. doi: 10.1097/00003072-199702000-00021.

Current readings in nuclear medicine.

Clin Nucl Med. 1997 May;22(5):352-4. doi: 10.1097/00003072-199705000-00047.

Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.

J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4.

引用本文的文献

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

EJNMMI Radiopharm Chem. 2024 May 16;9(1):42. doi: 10.1186/s41181-024-00268-w.

本文引用的文献

Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber.

J Nucl Med. 2023 Sep;64(9):1361-1363. doi: 10.2967/jnumed.123.266395. Epub 2023 Aug 17.

The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?

EJNMMI Radiopharm Chem. 2023 Aug 3;8(1):17. doi: 10.1186/s41181-023-00202-6.

Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.

J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4.

From radiotracer to radiopharmaceutical: a philosophical approach.

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):3-6. doi: 10.1007/s00259-021-05588-6.

Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET/CT in cancer patients.

Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385. doi: 10.1007/s00259-021-05307-1. Epub 2021 Jun 17.

Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Nat Rev Drug Discov. 2020 Sep;19(9):589-608. doi: 10.1038/s41573-020-0073-9. Epub 2020 Jul 29.

The role of fibroblast activation protein in health and malignancy.

Cancer Metastasis Rev. 2020 Sep;39(3):783-803. doi: 10.1007/s10555-020-09909-3.

Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6.

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

J Nucl Med. 2018 Sep;59(9):1415-1422. doi: 10.2967/jnumed.118.210443. Epub 2018 Apr 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Theragnostic: radiopharmaceuticals and nuclear medicine as viewed through Hegel's eyes.

Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):942-946. doi: 10.1007/s00259-023-06570-0.

Side effects of theragnostic agents currently employed in clinical practice.

Q J Nucl Med Mol Imaging. 2021 Dec;65(4):315-326. doi: 10.23736/S1824-4785.21.03411-7. Epub 2021 Dec 9.

Creuzerstreit .

J Hist Ideas. 2019;80(2):271-288. doi: 10.1353/jhi.2019.0015.

The 'Is' and the 'Ought' of the Animal Organism: Hegel's Account of Biological Normativity.

Hist Philos Life Sci. 2022 Apr 29;44(2):17. doi: 10.1007/s40656-022-00498-8.

Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging.

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3320-3321. doi: 10.1007/s00259-022-05768-y.

Progress in nuclear medicine imaging of cancers.

Prim Care. 1998 Jun;25(2):341-60. doi: 10.1016/s0095-4543(05)70068-3.

Radiopharmaceuticals and their use in the current practice of nuclear medicine.

Lippincotts Prim Care Pract. 1999 Nov-Dec;3(6):531-45.

Current readings in nuclear medicine.

Clin Nucl Med. 1997 Feb;22(2):136-9. doi: 10.1097/00003072-199702000-00021.

Current readings in nuclear medicine.

Clin Nucl Med. 1997 May;22(5):352-4. doi: 10.1097/00003072-199705000-00047.

Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.

J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4.

引用本文的文献

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

EJNMMI Radiopharm Chem. 2024 May 16;9(1):42. doi: 10.1186/s41181-024-00268-w.

本文引用的文献

Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber.

J Nucl Med. 2023 Sep;64(9):1361-1363. doi: 10.2967/jnumed.123.266395. Epub 2023 Aug 17.

The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?

EJNMMI Radiopharm Chem. 2023 Aug 3;8(1):17. doi: 10.1186/s41181-023-00202-6.

Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.

J Nucl Med. 2023 Jun;64(6):986-991. doi: 10.2967/jnumed.123.265603. Epub 2023 May 4.

From radiotracer to radiopharmaceutical: a philosophical approach.

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):3-6. doi: 10.1007/s00259-021-05588-6.

Head-to-head intra-individual comparison of biodistribution and tumor uptake of Ga-FAPI and F-FDG PET/CT in cancer patients.

Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4377-4385. doi: 10.1007/s00259-021-05307-1. Epub 2021 Jun 17.

Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Nat Rev Drug Discov. 2020 Sep;19(9):589-608. doi: 10.1038/s41573-020-0073-9. Epub 2020 Jul 29.

The role of fibroblast activation protein in health and malignancy.

Cancer Metastasis Rev. 2020 Sep;39(3):783-803. doi: 10.1007/s10555-020-09909-3.

Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6.

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

J Nucl Med. 2018 Sep;59(9):1415-1422. doi: 10.2967/jnumed.118.210443. Epub 2018 Apr 6.